Marsh & McLennan Cos Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $27.9B+14.3% YoYTTM through 30 Jun 2026
Net Income $4B-2.0% YoYTTM through 30 Jun 2026
Free Cash Flow $4.8BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 21.6% |
| Net Margin | 14.2% |
Returns
25.8%ROE
6.7%ROA
12.0%ROIC
Balance Sheet Health
Debt / Equity1.27x
Current Ratio1.14x
Net Debt$17.8B
Cash & Equivalents$1.7B
Quality Metrics
Altman Z-Score2.65
Piotroski F-Score7 / 9
FCF Margin17.1%
Rule of 4019.3
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $27B
Diluted EPS$8.19TTMFY2025: $8.43
Dividend
$2.79Per share, FY20261.64%Yield+6.9%5-yr growth
Capital Allocation
Capex Intensity1.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Risk and Insurance Services | $17.3B | +12.0% | View detailsManagement expects underlying revenue growth in 2026 to be similar to 2025, despite headwinds from lower interest rates and moderating insurance pricing. |
| Consulting | $9.8B | +7.0% | View detailsAnticipates continued margin expansion and solid adjusted EPS growth driven by health, wealth, and career advisory services. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.